New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.
Start Your Search

Healthy developments stirring in pharmaceutical contract manufacturing

Cel-Sci, Genzyme, and Pfizer announce contract manufacturing, outsourcing plans for drug and biopharmaceutical products.

Hp 19146 Hcp 2009 12
Reports from in-Pharma illustrate that production within the life science industry is off to an impressive start in this new year.

For example, the Web site reports that Cel-Sci has validated production equipment at its Baltimore, MD, GMP facility for aseptic filling and is ready to commence manufacture of its cancer drug Multikine. Once Cel-Sci has produced enough material for a Phase III trial of the drug, it says it will offer contract manufacturing services from the facility.

Earlier, in-Pharma noted that Genzyme was “outsourcing the fill and finish manufacturing of several major drugs to Hospira in response to in-house difficulties at its Allston Landing facility in Boston.”

Meanwhile, “Pfizer will soon sell more generic pharmaceuticals in the U.S. after its agreement with Indian non-branded drugmaker Strides Arcolab,” according to in-Pharma

These developments provide a beacon of hope for 2010.

-Jim Butschli, Editor, Healthcare Packaging
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts